ProQR to Present AX-0810 Phase 1 Data at AASLD Liver Meeting

• ProQR Therapeutics will present AX-0810 Phase 1 data Nov. 5 and 8 at AASLD’s Liver Meeting, Nov. 5-9, 2026, in Denver.
• A TIDES Europe presentation on Nov. 3, 2026, in Amsterdam will cover AX-0810 clinical findings and next-generation AX-0811 development.
• Nature’s RNA at the Bench and Bedside V on Dec. 9, 2026, will feature AX-0810 follow-up data and AX-0811 preclinical findings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610280800PRIMZONEFULLFEED1001280358) on October 28, 2026, and is solely responsible for the information contained therein.